Switch theme
Sign up to access all valuation multiples
Klea Holding focused on the acquisition, development and digitalization of companies in multiple sectors. Its development of Smart Salem, the first network of digital medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the Emirates United Arabs, or its Smart Health joint venture developed in Saudi Arabia.
2007
123
LTM Revenue $19.8M
LTM EBITDA $4.1M
$63.1M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Klea has a last 12-month revenue of $19.8M and a last 12-month EBITDA of $4.1M.
In the most recent fiscal year, Klea achieved revenue of $14.7M and an EBITDA of $6.3M.
Klea expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Klea valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $15.5M | $14.7M | XXX | XXX | XXX |
| Gross Profit | -$0.8M | $3.4M | XXX | XXX | XXX |
| Gross Margin | -5% | 23% | XXX | XXX | XXX |
| EBITDA | -$2.4M | $6.3M | XXX | XXX | XXX |
| EBITDA Margin | -15% | 43% | XXX | XXX | XXX |
| Net Profit | -$4.8M | -$5.7M | XXX | XXX | XXX |
| Net Margin | -31% | -39% | XXX | XXX | XXX |
| Net Debt | n/a | $3.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Klea's stock price is EUR 0 (or $0).
Klea has current market cap of EUR 55.9M (or $60.0M), and EV of EUR 58.8M (or $63.1M).
See Klea trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $63.1M | $60.0M | XXX | XXX | XXX | XXX | $0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Klea has market cap of $60.0M and EV of $63.1M.
Klea's trades at 3.2x LTM EV/Revenue multiple, and 15.4x LTM EBITDA.
Analysts estimate Klea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Klea and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $63.1M | XXX | XXX | XXX |
| EV/Revenue | 4.3x | XXX | XXX | XXX |
| EV/EBITDA | 10.0x | XXX | XXX | XXX |
| P/E | 62.0x | XXX | XXX | XXX |
| P/E/Growth | 0.6x | XXX | XXX | XXX |
| EV/FCF | -39.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpKlea's NTM/LTM revenue growth is 20%
Klea's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $47K for the same period.
Over next 12 months, Klea's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Klea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Klea and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -5% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 43% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -365% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 63% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $47K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 39% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Klea acquired XXX companies to date.
Last acquisition by Klea was XXXXXXXX, XXXXX XXXXX XXXXXX . Klea acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Klea founded? | Klea was founded in 2007. |
| Where is Klea headquartered? | Klea is headquartered in France. |
| How many employees does Klea have? | As of today, Klea has 123 employees. |
| Is Klea publicy listed? | Yes, Klea is a public company listed on PAR. |
| What is the stock symbol of Klea? | Klea trades under ALKLH ticker. |
| When did Klea go public? | Klea went public in 2011. |
| Who are competitors of Klea? | Similar companies to Klea include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Klea? | Klea's current market cap is $60.0M |
| What is the current revenue of Klea? | Klea's last 12-month revenue is $19.8M. |
| What is the current EBITDA of Klea? | Klea's last 12-month EBITDA is $4.1M. |
| What is the current EV/Revenue multiple of Klea? | Current revenue multiple of Klea is 3.2x. |
| What is the current EV/EBITDA multiple of Klea? | Current EBITDA multiple of Klea is 15.4x. |
| What is the current revenue growth of Klea? | Klea revenue growth between 2023 and 2024 was -5%. |
| Is Klea profitable? | Yes, Klea is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
